
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : VAL201
Therapeutic Area : Oncology
Study Phase : Phase I/ Phase II
Sponsor : ValiRx
Deal Size : Undisclosed
Deal Type : Collaboration
ValiRx plc Extension of Collaboration Agreement
Details : ValiRx will benefit from Physiomics' expertise in modelling the effects of prostate cancer care, as well as the latest version of its Virtual TumourTM technology, which will be used to extract useful information from the additional data provided by the V...
Product Name : Undisclosed
Product Type : Peptide, Unconjugated
Upfront Cash : Undisclosed
February 17, 2021
Lead Product(s) : VAL201
Therapeutic Area : Oncology
Highest Development Status : Phase I/ Phase II
Sponsor : ValiRx
Deal Size : Undisclosed
Deal Type : Collaboration
